Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Single-arm, Multi-center, Pharmacokinetic, Safety and Tolerability Study of Levetiracetam Intravenous Infusion in Children (4 - 16 Years Old) With Epilepsy.

NCT00535392 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00535392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00535392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Single-arm, Multi-center, Pharmacokinetic, Safety and Tolerability Study of Levetiracetam Intravenous Infusion in Children (4 - 16 Years Old) With Epilepsy.
Lead sponsor
UCB Pharma
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2007
Completion date
February 28, 2010
Enrollment
33 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy